OGN - Company ID 0001821825
The table below shows Organon & Co.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $574.00M | $675.00M | $693.00M | $706.00M | $737.00M |
| Short-term investments | - | - | - | - | - |
| Receivables | $1.33B | $1.36B | $1.74B | $1.48B | $1.38B |
| Inventory | $1.41B | $1.32B | $1.31B | $1.00B | $915.00M |
| Total current assets | $4.35B | $4.35B | $4.51B | $3.93B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.76B |
| Property, plant & equipment | $1.30B | $1.17B | $1.18B | $1.02B | $973.00M |
| Goodwill | $4.15B | $4.68B | $4.60B | $4.60B | $4.60B |
| Total assets | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B |
| Accounts payable | $952.00M | $1.15B | $1.31B | $1.13B | $1.38B |
| Total current liabilities | $2.39B | $2.72B | $2.92B | $2.51B | $2.60B |
| Long-term debt | $8.63B | $8.86B | $8.75B | $8.90B | $9.13B |
| Total liabilities | $12.12B | $12.63B | $12.13B | - | - |
| Retained earnings | $1.11B | $1.01B | $443.00M | -$331.00M | -$998.00M |
| Total equity | $752.00M | $472.00M | -$70.00M | -$892.00M | -$1.51B |